Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Excess adiposity is a reversible etiologic risk factor for obstructive sleep apnea. In this trial, tirzepatide reduced the apnea–hypopnea index of participants with obstructive sleep apnea and obesity.

​   The New England Journal of Medicine: Search Results in Pulmonary/Critical Care